Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 9 studies | 43% ± 17% | |
microglial cell | 8 studies | 32% ± 11% | |
retinal cone cell | 6 studies | 39% ± 14% | |
epithelial cell | 5 studies | 25% ± 5% | |
classical monocyte | 4 studies | 24% ± 9% | |
goblet cell | 4 studies | 26% ± 12% | |
myeloid cell | 4 studies | 18% ± 1% | |
macrophage | 4 studies | 26% ± 9% |
Insufficient scRNA-seq data for expression of HK2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 99% | 4300.04 | 1792 / 1809 | 96% | 66.45 | 452 / 472 |
breast | 95% | 4411.47 | 437 / 459 | 98% | 74.15 | 1095 / 1118 |
lung | 95% | 3234.59 | 551 / 578 | 91% | 79.59 | 1051 / 1155 |
ovary | 98% | 3983.96 | 176 / 180 | 82% | 27.29 | 352 / 430 |
thymus | 83% | 1612.53 | 542 / 653 | 86% | 56.07 | 518 / 605 |
stomach | 77% | 2260.50 | 276 / 359 | 90% | 59.09 | 258 / 286 |
bladder | 62% | 1682.29 | 13 / 21 | 96% | 68.56 | 485 / 504 |
intestine | 53% | 4490.82 | 510 / 966 | 96% | 82.60 | 508 / 527 |
esophagus | 45% | 1874.41 | 655 / 1445 | 97% | 89.19 | 178 / 183 |
prostate | 56% | 1183.76 | 137 / 245 | 85% | 30.13 | 426 / 502 |
uterus | 12% | 197.75 | 20 / 170 | 92% | 73.37 | 424 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.99 | 1 / 1 |
pancreas | 7% | 79.68 | 22 / 328 | 92% | 61.90 | 163 / 178 |
peripheral blood | 98% | 10234.28 | 908 / 929 | 0% | 0 | 0 / 0 |
adipose | 96% | 5860.61 | 1157 / 1204 | 0% | 0 | 0 / 0 |
kidney | 12% | 327.96 | 11 / 89 | 81% | 44.77 | 730 / 901 |
tonsil | 0% | 0 | 0 / 0 | 93% | 76.47 | 42 / 45 |
spleen | 93% | 1776.17 | 223 / 241 | 0% | 0 | 0 / 0 |
muscle | 86% | 7122.95 | 688 / 803 | 0% | 0 | 0 / 0 |
brain | 14% | 249.62 | 379 / 2642 | 67% | 23.32 | 472 / 705 |
blood vessel | 79% | 2436.38 | 1058 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 27.75 | 22 / 29 |
eye | 0% | 0 | 0 / 0 | 69% | 21.25 | 55 / 80 |
adrenal gland | 30% | 451.60 | 77 / 258 | 30% | 19.33 | 68 / 230 |
heart | 51% | 1278.24 | 440 / 861 | 0% | 0 | 0 / 0 |
liver | 5% | 71.79 | 12 / 226 | 13% | 4.77 | 51 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046835 | Biological process | carbohydrate phosphorylation |
GO_0002931 | Biological process | response to ischemia |
GO_0006096 | Biological process | glycolytic process |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0006002 | Biological process | fructose 6-phosphate metabolic process |
GO_1904925 | Biological process | positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_0008637 | Biological process | apoptotic mitochondrial changes |
GO_0061621 | Biological process | canonical glycolysis |
GO_0072656 | Biological process | maintenance of protein location in mitochondrion |
GO_0001666 | Biological process | response to hypoxia |
GO_0072655 | Biological process | establishment of protein localization to mitochondrion |
GO_0035795 | Biological process | negative regulation of mitochondrial membrane permeability |
GO_0007595 | Biological process | lactation |
GO_0051156 | Biological process | glucose 6-phosphate metabolic process |
GO_0006006 | Biological process | glucose metabolic process |
GO_0046324 | Biological process | regulation of glucose import |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0004396 | Molecular function | hexokinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0008865 | Molecular function | fructokinase activity |
GO_0005536 | Molecular function | D-glucose binding |
GO_0005515 | Molecular function | protein binding |
GO_0004340 | Molecular function | glucokinase activity |
Gene name | HK2 |
Protein name | Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) Phosphotransferase (EC 2.7.1.-) Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase) |
Synonyms | |
Description | FUNCTION: Catalyzes the phosphorylation of hexose, such as D-glucose and D-fructose, to hexose 6-phosphate (D-glucose 6-phosphate and D-fructose 6-phosphate, respectively) . Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate . Plays a key role in maintaining the integrity of the outer mitochondrial membrane by preventing the release of apoptogenic molecules from the intermembrane space and subsequent apoptosis . . |
Accessions | Q53SG7 E9PB90 P52789 ENST00000290573.7 ENST00000409174.1 Q53QX9 |